This writer digs into the CRISPR gene-editing space, asking whether one particular penny stock is worth taking a punt on in his ISA. The post Could buying this gene-editing penny stock at $1 make me ...

The Middle Eastern stock markets have recently faced challenges, with most Gulf indices declining due to trade war concerns ...

Shangar Decors shares finished Wednesday 0.62% higher at Rs 4.86 a share, with a market worth of Rs 47.59Cr, after the Board ...

Many analysts underappreciate Apple's services segment, which alone is worth $2 trillion, in my view. Read why AAPL stock is ...

We recently published a list of 12 Penny Stocks with Insider Buying in 2025. In this article, we are going to take a look at ...

As global markets navigate a landscape marked by declining consumer confidence and ongoing policy risks, investors are increasingly cautious about growth prospects. Amid these conditions, penny stocks ...

Why is this stock's price drop not as bad as it seems? Check out the hidden opportunity behind this innovator's mildly ...

With its buybacks-first approach, Scorpio now suffers an even bigger discount to NAV than Genco, trading at just 51%, ...

A contrarian investment strategy focused on accumulating assets during a sector's downturn and holding them for long-term ...

Highlights,Institutional investors modify their positions in Urban Edge Properties with varied stake increases and reductions ...

Hims & Hers' revenue channels witness strong growth on the back of solid product demand in the fourth quarter.

From a short-term perspective, Ford’s chart performance is mediocre at best, with overhead pressure from a downtrend line ...